Cell Source, Inc. CLCS OTC

Cell Source, Inc. (CLCS) reported total assets of $286.5K and total liabilities of $19.08M for quarter ending 2024-12-31, resulting in total equity of $-18.8M.

The company held $74.63K in cash and short-term investments. Total debt stood at $10.07M, with net debt of $9.99M. The Debt-to-Equity (D/E) ratio was -0.54 (conservative).

Current ratio is 0.02, which may signal tight short-term liquidity. Interest coverage is -3.2x (weak).

Criteria supported by this page:

• HEALTH (0/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
• MOAT (28/100) — Total assets $286.5K and equity $-18.8M support the company's competitive scale

Overall SharesGrow Score: 17/100 with 0/7 criteria passed.